Silva Arslanian-Makaroun
Pittsburgh, PANPI 1649242033
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $89,418 of the $128,356 with a category attached, or 69.7%. 13 manufacturers reported payments, led by Novo Nordisk AS at 36.0% of the total. Reporting peaked in 2024 at $50,626 and has fallen 79.0% since, to $10,635 in 2025.
Across 67 payments — averaging $1915.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$46K
- Eli Lilly$42K
- Novo Nordisk$13K
- Astrazeneca UK Limited$12K
- Sanofi-aventis U.S. LLC$8K
- Boehringer Ingelheim International GmbH$7K
- plus $1K from 7 others
Across 5,041 payments — averaging $250.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$1.1M
- Eli Lilly$183K
- Astrazeneca UK Limited$4K
What the payments were for
- Consulting fees$89,41870%
- Speaking & faculty fees$8,9177%
- Travel & lodging$28,26822%
- Food & beverage$1,6561%
- Education$970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 16 | $46,258 |
| Eli Lilly | 15 | $41,500 |
| Novo Nordisk | 15 | $12,541 |
| Astrazeneca UK Limited | 5 | $11,573 |
| Sanofi-aventis U.S. LLC | 2 | $8,242 |
| Boehringer Ingelheim International GmbH | 6 | $6,901 |
| Rhythm Pharmaceuticals, Inc. | 1 | $675 |
| W. L. Gore & Associates, Inc. | 2 | $309 |
| Amgen | 1 | $150 |
| Abbott | 1 | $124 |
| AstraZeneca | 1 | $36 |
| Medtronic | 1 | $26 |
| Chiesi USA, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$16,040
- TOUJEO$8,242
- ONGLYZA$7,073
- FARXIGA$4,500
- Victoza$4,163
- GORE VIABAHN VBX Balloon Expandable Endo$187
- FREESTYLE LIBRE 3$124
- GORE TAG Conformable Thoracic Endoprosthesis$122
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.